LI
PRTK

Leap Investments’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Leap Investments’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$109K Buy
20,904
+9,504
+83% +$42.2K 0.07% 352
2020
Q1 		$36K Buy
+11,400
New +$42.1K 0.05% 340

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Leap Investments's PRTK Position: Q2 2020 in Review

Leap Investments increased its Paratek Pharmaceuticals, Inc. (PRTK) stake by 83% in Q2 2020, buying an estimated $42.2K and bringing the position to 20,904 shares worth $109K. The position accounts for 0.07% of the portfolio, ranked #352.

Leap Investments first reported a position in PRTK in Q1 2020 and has held it in 2 quarters since. 99 funds tracked by Wall St. Rank hold PRTK as of Q2 2020.

  • Leap Investments held 20,904 shares of Paratek Pharmaceuticals, Inc. worth $109K as of Q2 2020.
  • Leap Investments bought 9,504 Paratek Pharmaceuticals, Inc. shares in Q2 2020, an estimated $42.2K.
  • Paratek Pharmaceuticals, Inc. made up 0.07% of Leap Investments's portfolio in Q2 2020, its #352 holding.
  • Leap Investments first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2020 and has held it in 2 quarters since.
  • 99 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.